1. Home
  2. ALBT vs NURO Comparison

ALBT vs NURO Comparison

Compare ALBT & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • NURO
  • Stock Information
  • Founded
  • ALBT 2014
  • NURO 1996
  • Country
  • ALBT United States
  • NURO United States
  • Employees
  • ALBT N/A
  • NURO N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • NURO Medical/Dental Instruments
  • Sector
  • ALBT Health Care
  • NURO Health Care
  • Exchange
  • ALBT Nasdaq
  • NURO Nasdaq
  • Market Cap
  • ALBT 9.5M
  • NURO 7.7M
  • IPO Year
  • ALBT N/A
  • NURO N/A
  • Fundamental
  • Price
  • ALBT $0.46
  • NURO $3.71
  • Analyst Decision
  • ALBT
  • NURO
  • Analyst Count
  • ALBT 0
  • NURO 0
  • Target Price
  • ALBT N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • ALBT 141.5K
  • NURO 8.0K
  • Earning Date
  • ALBT 08-12-2024
  • NURO 07-25-2024
  • Dividend Yield
  • ALBT N/A
  • NURO N/A
  • EPS Growth
  • ALBT N/A
  • NURO N/A
  • EPS
  • ALBT N/A
  • NURO N/A
  • Revenue
  • ALBT $959,516.00
  • NURO $5,270,210.00
  • Revenue This Year
  • ALBT N/A
  • NURO N/A
  • Revenue Next Year
  • ALBT N/A
  • NURO N/A
  • P/E Ratio
  • ALBT N/A
  • NURO N/A
  • Revenue Growth
  • ALBT 6.08
  • NURO N/A
  • 52 Week Low
  • ALBT $0.24
  • NURO $2.70
  • 52 Week High
  • ALBT $1.70
  • NURO $7.92
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 49.46
  • NURO 47.51
  • Support Level
  • ALBT $0.45
  • NURO $3.50
  • Resistance Level
  • ALBT $0.51
  • NURO $4.10
  • Average True Range (ATR)
  • ALBT 0.05
  • NURO 0.14
  • MACD
  • ALBT -0.01
  • NURO 0.01
  • Stochastic Oscillator
  • ALBT 36.46
  • NURO 35.00

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: